Skip to main content
Figure 1 | Breast Cancer Research

Figure 1

From: Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer

Figure 1

Kaplan–Meier estimates for recurrence-free survival between CYP2D6 genotypes in oestrogen-receptor-positive postmenopausal breast cancer patients. The black solid line represents patients homozygous for CYP2D6*1, the grey solid line represents heterozygous patients, and the dotted line represents patients homozygous for CYP2D6*4. P = 0.05 between *4/*4 and *1/*1; P = 0.04 between *4/*4 and *1/*4; P = 0.16 between *1/*1 and *1/*4.

Back to article page